Discover the importance of antibiotics, bacterial cell walls, and resistance mechanisms in fighting bacterial infections effectively.

It's the first and only such therapy approved to fight antimicrobial resistance, or AMR, in bacterial infections.

AbbVie said on Friday that the U.S. Food and Drug Administration approved its drug for complicated intra-abdominal infections ...

BBC Morning Live's resident GP, doctor Punam Krishan, has said that people need to be careful about how and when they take ...

NORTH CHICAGO, Ill. - The U.S. Food and Drug Administration (FDA) has approved EMBLAVEO™ (aztreonam and avibactam) for the ...

Most of Dr. Leah Schrupp’s patients know it. So do most of Dr. Erin Knudtson’s patients. If they visit their doctor with a runny nose, chest cold or the usual flu symptoms, they ...

BBC Morning Live's resident GP, doctor Punam Krishan, has warned people to be cautious about how and when they take ...

The FDA has approved the intravenous antibiotic Emblaveo for adults with complicated intra-abdominal infections who have limited treatment options.

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

AbbVie received Food and Drug Administration approval of Emblaveo, an intravenous antibiotic, for treatment of adults with complicated intra-abdominal infections with limited or no treatment options.